BioGenerator | St. Louis Public Radio


Taken on July 22 at BioSTL building in cortex during rehab construction.
Corinne Ruff | St. Louis Public Radio

A historic building in the Cortex innovation district is being transformed into a focal point for the St. Louis bioscience industry. At least that’s the intention of BioSTL President and CEO Donn Rubin.

“It’s part of my vision that when a guest to St. Louis comes for a meeting in the biosciences, they will be exposed to not just one company or one entrepreneur, but see an entire community of entrepreneurs — a beehive of startup activity.”

(Illustration by Susannah Lohr, St. Louis Public Radio)

In May of last year, BioGenerator officials crunched the numbers and realized about a  dozen companies in their portfolio would need to raise $60 to $90 million in order to keep growing.

BioGenerator, which formed in 2003, is a sort of incubator for biotech companies in St. Louis, providing early stage funding and support for 65 companies to date.

BioGenerator has put new space in old.
Provided | 2013

This article originally appeared in the St. Louis Beacon. -  St. Louis’s BioGenerator will host an open house tomorrow to mark its recent expansion into new space in the region’s growing tech district.

“Brick walls, concrete floors,” said Donn Rubin, president and CEO of BioSTL, which oversees the incubator. “It’s very urban and gritty – a very cool space.”

This article first appeared in the St. Louis Beacon, Oct. 24, 2012 - Think about mind-reading, and the images that pop to the fore are old-time mentalists and glitzy magicians.

But at one St. Louis area company, the magic is no stage act: At Neurolutions, a very real kind of mind-reading is happening. The company has developed a headset that offers hope to stroke victims as they try to recover from debilitating brain injuries. The headset operates a special glove that responds to the wearer’s thoughts.

This article first appeared in the St. Louis Beacon, Oct. 23, 2012 - Local entrepreneurial leaders have rolled out a major investment in St. Louis’ technology field. It's one they hope will spur the emergence of a full-scale innovation corridor and lay the groundwork for a uniquely revitalized area of the city with a complete slate of cultural, retail and residential opportunities.

This article first appeared in the St. Louis Beacon, March 11, 2012 - Chad Stiening acknowledges that there is some degree of irony in the name of his company. After all, Kypha isn’t some quirky nomenclature that comes from a sci-fi nerd’s love affair with an obscure TV show nor is it a futuristic moniker inspired by the cold machinations of some corporate focus group.

It’s simply short for Kentucky Pharmaceuticals.

This article first appeared in the St. Louis Beacon, Sept. 28, 2011 - Donn Rubin will tell you it's not very flashy.

"We're not trying to build an empire here," he laughs.